Department of Pharmacology, Rush University, 1735 W. Harrison St., Chicago, IL 60612, USA.
Apoptosis. 2013 Jan;18(1):57-76. doi: 10.1007/s10495-012-0762-x.
Intersectin-1s (ITSN-1s) is a general endocytic protein involved in regulating lung vascular permeability and endothelial cells (ECs) survival, via MEK/Erk1/2(MAPK) signaling. To investigate the in vivo effects of ITSN-1s deficiency and the resulting ECs apoptosis on pulmonary vasculature and lung homeostasis, we used an ITSN-1s knocked-down (KD(ITSN)) mouse generated by repeated delivery of a specific siRNA targeting ITSN-1 gene (siRNA(ITSN)). Biochemical and histological analyses as well as electron microscopy (EM) revealed that acute KD(ITSN) [3-days (3d) post-siRNA(ITSN) treatment] inhibited Erk1/2(MAPK) pro-survival signaling, causing significant ECs apoptosis and lung injury; at 10d of KD(ITSN), caspase-3 activation was at peak, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)-positive ECs showed 3.4-fold increase, the mean linear intercept (MLI) showed 48 % augment and pulmonary microvessel density as revealed by aquaporin-1 staining (AQP-1) decreased by 30 %, all compared to controls; pulmonary function was altered. Concomitantly, expression of several growth factors known to activate Erk1/2(MAPK) and suppress Bad pro-apoptotic activity increased. KD(ITSN) altered Smads activity, downstream of the transforming growth factor beta-receptor-1 (TβR1), as shown by subcellular fractionation and immunoblot analyses. Moreover, 24d post-siRNA(ITSN), surviving ECs became hyper-proliferative and apoptotic-resistant against ITSN-1s deficiency, as demonstrated by EM imaging, 5-bromo-deoxyuridine (BrdU) incorporation and Bad-Ser(112/155) phosphorylation, respectively, leading to increased microvessel density and repair of the injured lungs, as well as matrix deposition. In sum, ECs endocytic dysfunction and apoptotic death caused by KD(ITSN) contribute to the initial lung injury and microvascular loss, followed by endothelial phenotypic changes and microvascular remodeling in the remaining murine pulmonary microvascular bed.
衔接蛋白-1s(ITSN-1s)是一种参与调节肺血管通透性和内皮细胞(ECs)存活的通用内吞蛋白,通过 MEK/Erk1/2(MAPK)信号通路。为了研究 ITSN-1s 缺失及其导致的 ECs 凋亡对肺血管和肺稳态的体内影响,我们使用了一种通过重复递送靶向 ITSN-1 基因的特定 siRNA 产生的 ITSN-1 敲低(KD(ITSN)) 小鼠(siRNA(ITSN))。生化和组织学分析以及电子显微镜(EM)显示,急性 KD(ITSN)(siRNA(ITSN) 治疗后 3 天)抑制了 Erk1/2(MAPK)促存活信号,导致显著的 ECs 凋亡和肺损伤;在 KD(ITSN) 的 10 天,半胱天冬酶-3 激活达到峰值,末端脱氧核苷酸转移酶 dUTP 缺口末端标记(TUNEL)阳性 ECs 增加了 3.4 倍,平均线性截距(MLI)增加了 48%,肺微血管密度如 Aquaporin-1 染色(AQP-1)所示减少了 30%,与对照组相比均有显著差异;肺功能发生改变。同时,几种已知激活 Erk1/2(MAPK)和抑制 Bad 促凋亡活性的生长因子的表达增加。KD(ITSN)改变了转化生长因子β受体-1(TβR1)下游的 Smads 活性,如亚细胞分级和免疫印迹分析所示。此外,在 siRNA(ITSN) 后 24 天,存活的 ECs 对 ITSN-1s 缺乏变得过度增殖和抗凋亡,如 EM 成像、5-溴-2-脱氧尿苷(BrdU)掺入和 Bad-Ser(112/155)磷酸化所示,导致微血管密度增加和受损肺的修复以及基质沉积。总之,KD(ITSN)引起的 ECs 内吞功能障碍和凋亡死亡导致初始肺损伤和微血管丢失,随后在剩余的小鼠肺微血管床中引起内皮表型变化和微血管重塑。